Article info
Molecules in pathogenesis
CDK12: an emerging therapeutic target for cancer
- Correspondence to Dr Goldie Y L Lui, Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; glui{at}fredhutch.org
Citation
CDK12: an emerging therapeutic target for cancer
Publication history
- Received June 26, 2018
- Revised July 25, 2018
- Accepted July 26, 2018
- First published August 13, 2018.
Online issue publication
October 17, 2018
Article Versions
- Previous version (13 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.